- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06628830
Efficacy of a Mobile Phone App for Depression and Anxiety in College Students (VamosJuntxs)
Efficacy of a Mobile Phone Application for Early Intervention of Depression and Anxiety in Young College Students
The goal of this clinical trial is to evaluate the efficacy of a mobile phone application for the early intervention of depression and anxiety among young university students in Chile. The main question it aims to answer is:
- Can a mobile app reduce depressive and anxious symptomatology in college students?
Researchers will compare the intervention arm (mobile app users) to the control group (receives psychoeducational material and mental health care resources) to see if the app leads to significant improvements in depressive and anxious symptoms and well-being.
Participants will:
- Be randomly assigned to either the intervention or control group.
- Use the mobile application, which includes psychoeducational materials, cognitive-behavioral therapy modules, and periodic personalized feedback.
- Complete assessments at baseline, post-intervention, and 3 and 6 months after randomization using online tools such as the PHQ-9 for depressive symptoms and the GAD-7 for anxious symptoms.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Region Metropolitana
-
Santiago, Region Metropolitana, Chile, 8380455
- CEMERA, Faculty of Medicine, Universidad de Chile
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- PHQ-9 and GAD-7 score between 5 and 14 points
- Have a stable internet connection
- To provide informed consent
Exclusion Criteria:
- High risk of suicide according to C-SSRS
- Currently undergoing psychological, psychiatric and/or psychopharmacological treatment
- Bipolar disorder, psychotic disorder or substance use disorder assessed with the respective modules of the MINI interview.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
The intervention consists of an indicated prevention program delivered through a mobile app. The program will last 6 weeks and includes the following:
Additionally, participants will be able to access additional help resources that include a speed dial button for a suicide prevention hotline and a web link to access contact information for mental health services. Finally, the intervention protocol also includes the eventual referral to face-to-face mental health care if required. |
Psychoeducational materials (videos, information and interactive exercises) about depression, anxiety and social support Skills training through information and activities based on the principles of cognitive behavioral therapy (cognitive restructuring, behavioral activation, emotional regulation, problem solving and exposure) |
|
Active Comparator: Control Group
Participants in the enhanced control group will receive a web link (https://concienciasaludable.uchile.cl/)
with information about places to go to seek mental health care both inside and outside the respective university and psychoeducational material on depression and anxiety
|
mental health psychoeducational campaign (https://concienciasaludable.uchile.cl/)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression symptoms
Time Frame: 6-weeks post-randomization
|
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
|
6-weeks post-randomization
|
|
Anxiety symptoms
Time Frame: 6-weeks post-randomization
|
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
|
6-weeks post-randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Well-being
Time Frame: 6-weeks post-randomization
|
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
|
6-weeks post-randomization
|
|
User Satisfaction
Time Frame: 6-weeks post-randomization
|
Ad-hoc satisfaction questionnaire for the intervention group, total score varies between 7 and 28, higher values represent a better outcome and an overall index with values ranging from 1 to 10
|
6-weeks post-randomization
|
|
Depression symptoms
Time Frame: 3-months post-randomization
|
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
|
3-months post-randomization
|
|
Anxiety symptoms
Time Frame: 3-months post-randomization
|
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
|
3-months post-randomization
|
|
Well-being
Time Frame: 3-months post-randomization
|
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
|
3-months post-randomization
|
|
Depression symptoms
Time Frame: 6-months post-randomization
|
PHQ-9, total score varies between 0 and 27, higher values represent a worse outcome
|
6-months post-randomization
|
|
Anxiety symptoms
Time Frame: 6-months post-randomization
|
GAD-7, total score varies between 0 and 21, higher values represent a worse outcome
|
6-months post-randomization
|
|
Well-being
Time Frame: 6-months post-randomization
|
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS), total score varies between 7 and 35, higher values represent a better outcome
|
6-months post-randomization
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fondecyt 1221230
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depressive Symptoms
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
University of California, San DiegoRecruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
Julia EderNot yet recruitingDepressive Disorder | Depression | Depressive Symptoms | Major Depressive Disorder | Depressive EpisodeGermany
-
Finnish Institute for Health and WelfareUniversity of Helsinki; Tampere University; University of Eastern Finland; Strategic...RecruitingMajor Depressive Disorder | Depressive Symptoms Mild to Moderate in SeverityFinland
-
Uppsala UniversityRecruitingPostpartum | Attachment | Depression - Major Depressive DisorderSweden
-
Mental Health Services in the Capital Region, DenmarkHospital del Mar Research Institute (IMIM); Research Centre of the German Foundation... and other collaboratorsEnrolling by invitationDepression - Major Depressive Disorder | Mental DistressSpain, Germany, Denmark
-
Medical Research CouncilKU LeuvenCompletedDepressive Symptoms | Major Depressive DisorderAustralia
-
Massachusetts General HospitalCompletedMajor Depressive DisorderUnited States, China
-
Dr. Nazanin AlaviCompletedDepression | Depressive Symptoms | Major Depressive DisorderCanada
-
Linkoeping UniversityCompletedMajor Depressive DisorderSweden
Clinical Trials on VamosJuntxs App
-
University of VictoriaRecruiting
-
Hypnalgesics, LLCTufts UniversityCompletedDental Anxiety | Opioid Use | Drug Use | Dental PainUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedCancer | Financial Toxicity | Question Prompt ListUnited States
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
The University of Hong KongNot yet recruitingDigital Health | Knee Pain/OsteoarthritisHong Kong
-
Institute for Human Development and Potential (IHDP)...Active, not recruitingType 2 Diabetes | Gestational Diabetes | Healthy Lifestyle BehaviorsSingapore
-
University of California, San FranciscoConquer Cancer FoundationCompletedProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Big Health Inc.National Institute of Mental Health (NIMH); Duke UniversityActive, not recruiting
-
University Hospitals Cleveland Medical CenterCompleted
-
New York UniversityJoon, Inc.RecruitingDepression | Stress | Anxiety | Executive Dysfunction | Behavior, Child | Disruptive Behavior | Attention-deficitUnited States